IHH Healthcare Berhad

KLSE:IHH Stock Report

Market Cap: RM 77.6b

IHH Healthcare Berhad Valuation

Is IHH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of IHH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: IHH (MYR8.78) is trading below our estimate of future cash flow value (MYR12.63)

Significantly Below Future Cash Flow Value: IHH is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for IHH?

Key metric: As IHH is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for IHH. This is calculated by dividing IHH's market cap by their current earnings.
What is IHH's PE Ratio?
PE Ratio36.7x
EarningsRM 2.12b
Market CapRM 77.58b

Price to Earnings Ratio vs Peers

How does IHH's PE Ratio compare to its peers?

The above table shows the PE ratio for IHH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average36.9x
SUNMED Sunway Healthcare Holdings Berhad
83.4x24.17%RM 20.6b
KPJ KPJ Healthcare Berhad
36.7x9.57%RM 13.9b
FOCUSP Focus Point Holdings Berhad
8.8x8.85%RM 319.8m
PMCK PMCK Berhad
18.8x6.77%RM 212.7m
IHH IHH Healthcare Berhad
36.7x12.93%RM 77.6b

Price-To-Earnings vs Peers: IHH is good value based on its Price-To-Earnings Ratio (36.7x) compared to the peer average (36.9x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does IHH's PE Ratio compare vs other companies in the Asian Healthcare Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
IHH 36.7xIndustry Avg. 18.9xNo. of Companies71PE01632486480+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: IHH is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the Asian Healthcare industry average (18.7x).

Price to Earnings Ratio vs Fair Ratio

What is IHH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IHH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio36.7x
Fair PE Ratio30.5x

Price-To-Earnings vs Fair Ratio: IHH is expensive based on its Price-To-Earnings Ratio (36.7x) compared to the estimated Fair Price-To-Earnings Ratio (30.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IHH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 8.78
RM 10.13
+15.41%
7.80%RM 11.43RM 8.50n/a23
Jun ’27RM 9.01
RM 10.13
+12.46%
7.80%RM 11.43RM 8.50n/a23
May ’27RM 8.82
RM 10.01
+13.54%
8.93%RM 11.59RM 8.25n/a23
Apr ’27RM 8.96
RM 9.97
+11.23%
8.39%RM 11.43RM 8.25n/a23
Mar ’27RM 9.12
RM 9.18
+0.70%
10.83%RM 11.43RM 7.45n/a22
Feb ’27RM 8.96
RM 8.89
-0.80%
8.00%RM 10.00RM 7.45n/a21
Jan ’27RM 8.75
RM 8.86
+1.21%
7.65%RM 9.70RM 7.45n/a21
Dec ’26RM 8.40
RM 8.86
+5.43%
7.66%RM 9.70RM 7.45n/a21
Nov ’26RM 8.25
RM 8.52
+3.32%
8.04%RM 9.60RM 7.45n/a21
Oct ’26RM 7.94
RM 8.33
+4.92%
7.75%RM 9.60RM 7.45n/a21
Sep ’26RM 6.79
RM 8.30
+22.27%
7.60%RM 9.60RM 7.20n/a21
Aug ’26RM 6.68
RM 8.25
+23.48%
6.36%RM 9.15RM 7.20n/a21
Jul ’26RM 6.80
RM 8.24
+21.24%
6.28%RM 9.10RM 7.20n/a21
Jun ’26RM 6.90
RM 8.24
+19.48%
6.28%RM 9.10RM 7.20RM 9.0121
May ’26RM 6.92
RM 8.24
+19.14%
5.58%RM 9.10RM 7.30RM 8.8221
Apr ’26RM 6.92
RM 8.25
+19.28%
5.51%RM 9.10RM 7.30RM 8.9621
Mar ’26RM 7.45
RM 7.85
+5.35%
16.92%RM 9.10RM 2.58RM 9.1220
Feb ’26RM 7.16
RM 8.14
+13.67%
7.21%RM 9.10RM 6.90RM 8.9621
Jan ’26RM 7.30
RM 8.08
+10.67%
7.16%RM 9.10RM 6.90RM 8.7521
Dec ’25RM 7.26
RM 8.02
+10.47%
7.07%RM 9.10RM 7.10RM 8.4021
Nov ’25RM 7.28
RM 7.68
+5.53%
5.93%RM 8.80RM 6.88RM 8.2521
Oct ’25RM 7.24
RM 7.56
+4.44%
5.63%RM 8.80RM 6.88RM 7.9421
Sep ’25RM 6.27
RM 7.47
+19.13%
5.60%RM 8.00RM 6.40RM 6.7921
Aug ’25RM 6.32
RM 7.30
+15.54%
5.97%RM 8.00RM 6.40RM 6.6821
Jul ’25RM 6.30
RM 7.26
+15.23%
6.24%RM 8.00RM 6.40RM 6.8021
Jun ’25RM 6.19
RM 7.22
+16.68%
5.99%RM 7.90RM 6.40RM 6.9020
RM 10.13
Fair Value
13.3% undervalued intrinsic discount
23
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/14 05:23
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IHH Healthcare Berhad is covered by 30 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ken-Wern LimAffin Hwang Investment Bank
Khir GohAmInvestment Bank Berhad
Laura Emmet CarneyBernstein